Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.4% |
| 2 | Healthcare | 3.08% |
| 3 | Financials | 2.41% |
| 4 | Consumer Discretionary | 2.33% |
| 5 | Industrials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
Krystal Biotech
KRYS
$9.83B
| $4.45M | ﹤0.01% |
25,014
+16,815
| +205% | +$2.34M |
|
4052
LeMaitre Vascular
LMAT
$1.88B
| $4.45M | ﹤0.01% |
67,066
+16,084
| +32% | +$992K |
|
4053
CALL
Wendy's
WEN
$1.65B
| $4.45M | ﹤0.01% |
236,200
-155,900
| -40% | -$2.93M |
|
4054
CALL
PagerDuty
PD
$918M
| $4.44M | ﹤0.01% |
195,800
+39,200
| +25% | +$931K |
|
4055
Hecla Mining
HL
$12.3B
| $4.44M | ﹤0.01% |
922,277
-92,184
| -9% | -$368K |
|
4056
PUT
Commercial Metals
CMC
$7.92B
| $4.43M | ﹤0.01% |
75,400
-24,800
| -25% | -$1.31M |
|
4057
ClearShares Ultra-Short Maturity ETF
OPER
$105M
| $4.43M | ﹤0.01% |
44,206
+15,917
| +56% | +$1.6M |
|
|
CWAN
4058
DELISTED
Clearwater Analytics
CWAN
| $4.43M | ﹤0.01% |
250,192
-554,300
| -69% | -$10.3M |
|
4059
Rapid7
RPD
$876M
| $4.42M | ﹤0.01% |
90,096
-665,838
| -88% | -$36.5M |
|
4060
ProShares UltraShort Bloomberg Natural Gas
KOLD
$105M
| $4.42M | ﹤0.01% |
56,384
-63,938
| -53% | -$3.9M |
|
|
VRN
4061
DELISTED
Veren
VRN
| $4.42M | ﹤0.01% |
539,260
+148,281
| +38% | +$1.04M |
|
4062
JPMorgan Active Value ETF
JAVA
$7.2B
| $4.42M | ﹤0.01% |
+73,730
| New | +$4.18M |
|
4063
PUT
Hercules Capital
HTGC
$3.13B
| $4.41M | ﹤0.01% |
239,200
+156,900
| +191% | +$2.79M |
|
4064
Suzano
SUZ
$9.99B
| $4.41M | ﹤0.01% |
345,293
+271,631
| +369% | +$3.06M |
|
4065
Asbury Automotive
ABG
$3.78B
| $4.41M | ﹤0.01% |
18,713
-39,565
| -68% | -$8.4M |
|
4066
CALL
Veralto
VLTO
$23.8B
| $4.4M | ﹤0.01% |
49,611
-62,245
| -56% | -$5.16M |
|
4067
CALL
Bio-Rad Laboratories Class A
BIO
$9.53B
| $4.39M | ﹤0.01% |
12,700
-14,600
| -53% | -$4.8M |
|
4068
Jacobs Solutions
J
$16.9B
| $4.39M | ﹤0.01% |
34,525
-54,853
| -61% | -$6.43M |
|
4069
PUT
Chord Energy
CHRD
$7.51B
| $4.38M | ﹤0.01% |
24,600
-6,400
| -21% | -$1.03M |
|
|
AUTL
4070
Autolus Therapeutics
AUTL
$572M
| $4.38M | ﹤0.01% |
686,480
+646,715
| +1,626% | +$4.03M |
|
4071
PUT
Leidos
LDOS
$18B
| $4.38M | ﹤0.01% |
33,400
-800
| -2% | -$95.4K |
|
4072
Collegium Pharmaceutical
COLL
$875M
| $4.38M | ﹤0.01% |
112,743
+2,235
| +2% | +$78.2K |
|
4073
PUT
Oscar Health
OSCR
$10.1B
| $4.37M | ﹤0.01% |
294,200
+249,600
| +560% | +$3.42M |
|
4074
PUT
Main Street Capital
MAIN
$5.5B
| $4.37M | ﹤0.01% |
92,400
+80,400
| +670% | +$3.63M |
|
4075
TransDigm Group
TDG
$69.5B
| $4.37M | ﹤0.01% |
3,549
-29,282
| -89% | -$33M |
|
Similar funds
Ken Griffin's Q1 2024 Portfolio in Review
As of Q1 2024, Ken Griffin held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in TD Synnex worth $245M.
- Ken Griffin's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Ken Griffin added most to Hess in Q1 2024, an estimated $1.28B increase.
- Ken Griffin's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Ken Griffin fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Ken Griffin opened 1,749 new positions and closed 1,439 in Q1 2024.
- Ken Griffin's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.